@thewrap.com looks at M&A so far this year: media VC deals are falling – 70% year over year – compared to AI which is soaring. Here’s the story in charts, in partnership with #PitchBook: www.thewrap.com/industry-new...
The narrative has officially shifted: China is no longer a "fast-follower"—it has become the global engine for First-in-Human (FIH) innovation.As an investor, three data points from this report stand out as strategic signals for the year ahead: 1. The Efficiency Moat: Since 2021, China has registered nearly twice as many FIH trials for next-gen antibodies (ADCs, bispecifics) as the U.S. and Europe combined. In an era where "speed to data" is everything, China’s clinical infrastructure is delivering results at a fraction of the cost. 2. From "Me-Too" to "High-Complexity": Modality mix is evolving rapidly. In 2025, cell and gene therapies (CGT) and nucleic acid assets accounted for 50% of deal volume in China. We are seeing a massive shift toward high-complexity assets that global MNCs are eager to integrate into their pipelines. 3. The Arbitrage Opportunity: Western pharmas are essentially "acquiring de-risked innovation hubs" via licensing rather than full M&A. With U.S. early-stage assets facing funding constraints, the cross-border licensing of underfunded but clinically superior Chinese assets is the most capital-efficient way to bridge the "patent cliff." My Take: The "China Edge" is likely to persist for years. The massive spike in innovative drug submissions—from 688 in 2019 to nearly 2,300 in 2023—is just now reaching the peak of its value realization. For LPs and GPs, the question isn't whether to have exposure to China-originated assets, but how to structure the partnerships to navigate the geopolitical noise while capturing the scientific alpha. Source: [https://lnkd.in/ezEfyWRm](https://lnkd.in/ezEfyWRm)
Why China’s early-stage drugmaking edge is the most compelling “de-risked” opportunity in 2026.
The latest Pitchbook analyst note on the Chinese biopharma landscape is a wake-up call for global asset allocators.
#BCIC #VentureCapital #Pitchbook #ChinaBiotech #AssetAllocation #CGT #ADC
Catching up with our former intern Vanessa Ho at the GFTN Connect x PitchBook x Qapita session!
#singapore #questventures #venturecapital #priteequity #catchup #event #catchup #GFTNConnect #PitchBook #Qapita #SuperReturnAsia #asia
New PitchBook and Web Summit Investor Survey Finds AI Playing a Growing Role in Investment Decisions PitchBook, the leading private capital market intelligence provider, released findings from its ...
#Artificial #Intelligence #Investment #Services #News #PitchBook
Origin | Interest | Match
Monday, November 10, 2025: Microsoft exposes #Whisper Leak vulnerability compromising encrypted AI chats; Apple extends iPhone satellite capabilities, #Pitchbook launches deal #AI, Google's Opal gets spammy...
deadstack.beehiiv.com/p/afternoon-...
PitchBook brings generative AI to private markets with Navigator and ChatGPT integration #Technology #Business #Startups #GenerativeAI #PrivateMarkets #PitchBook
From January through August of this year, #sovereign wealth funds participated in #AI venture deals worth $46.4 billion overall, with $43.3 billion (over 93%) of this funding going to US startups, according to #PitchBook data. #startups #VC pitchbook.com/news/article... #AbuDhabi #oman
OpenAI introduces mentorship program to support tech entrepreneurs OpenAI has launched its Groove program that targets early entrepreneurs looking to build with artificial intelligence. OpenAI has ...
#Tech #OpenAI #PitchBook
Origin | Interest | Match
OpenAI introduces mentorship program to support tech entrepreneurs OpenAI has launched its Groove program that targets early entrepreneurs looking to build with artificial intelligence. OpenAI has ...
#Tech #OpenAI #PitchBook
Origin | Interest | Match
Only 33% of 2021 first-time VC funds raised a second fund—just 12% from 2022. Capital concentrates in big firms as LPs demand liquidity. 💰📉
#goodrevenue #VentureCapital #Investing #PitchBook #Economy #Markets #Funds #Innovation #Business #Startups #viral #trending
Navigating the Evolving Landscape of Venture Debt Financing #USA #Menlo_Park #Runway_Growth #PitchBook #Venture_Debt
"More than 36% of European football clubs in the 'Big Five' leagues this season have financial backing from private equity, venture capital or private debt firms at the start of the 2025-2026 season." (Jordan Rubio, Nicolas Moura, James Thorne / #Pitchbook) pitchbook.com/news/article...
#artificial-intelligence-startup #venture-capital-fundraising #venture-capital #startup-funding #artificial-intelligence #united-states #pitchbook #startup #investment-trends #tech-investment #funding-surge #capital-raising #second-best-year #finance #2025 #market-trend
2019, bad vintage year for the VCs
#VC #Argo #Deals #Pitchbook #valuation #DPI
Kroll Enhances Private Capital Markets Platform with Advanced Credit Analysis Tools #United_States #New_York #Kroll #Morningstar #PitchBook
越来越多的欧洲公司选择在欧洲以外的交易所上市。2024年,欧洲公司在欧洲交易所上市的比例跌至历史最低水平。
来源: #PitchBook
💰 A need for liquidity
LPs need cash to reinvest. According to #Pitchbook, 30 firms raised 75% of all capital raised by VC funds in the US, a powerful signal of how the tech pullback is concentrating influence among the venture industry’s heavyweights.
数据提供商 #PitchBook 的数据显示,去年美国 #风险投资 公司向投资者返还了价值260亿美元的收益,为2011年以来的最低水平。预计2024年仍将延续这一趋势,因为收购交易或 #首次公开募股 ( #IPO ) 很少。去年,美国风险投资公司的投资额比收益高出600亿美元,这是PitchBook有数据以来的最高水平。 来源:#华尔街日报
#GenerativeAI #funding reached new heights in 2024.
According to #data from financial tracker #PitchBook compiled for #TechCrunch , generative AI companies worldwide #raised $56 billion from #VCs in 2024 across 885 #deals. techcrunch.com/2025/01/03/g... via @techcrunch #startups #startupecosystems